https://psychedelicalpha.com/ 2026-11-13T17:11:16+00:00 https://psychedelicalpha.com/insights/ 2026-11-13T17:10:31+00:00 https://psychedelicalpha.com/practitioner/ 2026-10-16T12:03:08+00:00 https://psychedelicalpha.com/psychedelic-healthcare-forum-2026/ 2026-10-06T16:42:22+00:00 https://psychedelicalpha.com/join/ 2026-10-01T21:12:39+00:00 https://psychedelicalpha.com/resources/psychedelic-drug-development-tracker/ 2026-10-01T14:46:53+00:00 https://psychedelicalpha.com/resources/federal-psychedelics-lobbying-tracker/ 2026-09-28T12:12:39+00:00 https://psychedelicalpha.com/ai/ 2026-09-16T15:46:29+00:00 https://psychedelicalpha.com/home/ 2026-08-31T16:16:51+00:00 https://psychedelicalpha.com/resources/the-oregon-psilocybin-services-tracker/ 2026-07-28T14:50:30+00:00 https://psychedelicalpha.com/resources/psychedelic-company-financing-tracker/ 2026-07-22T16:42:01+00:00 https://psychedelicalpha.com/resources/psychedelic-laws/ 2026-07-22T13:27:10+00:00 https://psychedelicalpha.com/resources/worldwide-psychedelic-laws/ 2026-06-18T09:23:00+00:00 https://psychedelicalpha.com/resources/ 2026-06-12T10:43:40+00:00 https://psychedelicalpha.com/resources/psychedelic-nonprofit-financing-tracker/ 2026-06-12T10:33:15+00:00 https://psychedelicalpha.com/resources/psychedelic-companies-directory/ 2026-06-05T08:06:30+00:00 https://psychedelicalpha.com/resources/non-hallucinogenic-psychedelic-pipeline-tracker/ 2026-04-30T14:23:48+00:00 https://psychedelicalpha.com/resources/psychedelic-stocks-tracker/ 2026-04-17T11:04:03+00:00 https://psychedelicalpha.com/resources/psychedelic-readout-tracker/ 2026-04-10T10:20:48+00:00 https://psychedelicalpha.com/resources/lsd-patent-tracker/ 2026-03-13T14:21:01+00:00 https://psychedelicalpha.com/advisory/ 2026-03-10T21:29:26+00:00 https://psychedelicalpha.com/cookies-policy/ 2026-03-10T14:24:35+00:00 https://psychedelicalpha.com/privacy-policy/ 2026-03-10T11:13:10+00:00 https://psychedelicalpha.com/resources/psychedelics-glossary/ 2026-03-09T20:28:39+00:00 https://psychedelicalpha.com/resources/the-psychedelics-perceptions-tracker/ 2026-03-09T20:27:23+00:00 https://psychedelicalpha.com/resources/psychedelic-bill-tracker/ 2026-03-09T20:26:04+00:00 https://psychedelicalpha.com/resources/oregon-psilocybin-tracker/ 2026-03-09T19:40:24+00:00 https://psychedelicalpha.com/latest/ 2026-03-09T19:33:33+00:00 https://psychedelicalpha.com/live/ 2026-03-09T19:32:40+00:00 https://psychedelicalpha.com/contact/ 2026-03-09T19:27:41+00:00 https://psychedelicalpha.com/resources/psilocybin-patent-tracker/ 2026-03-09T17:15:16+00:00 https://psychedelicalpha.com/resources/dmt-patent-tracker/ 2026-03-09T17:14:47+00:00 https://psychedelicalpha.com/resources/ketamine-patent-tracker/ 2026-03-09T17:14:17+00:00 https://psychedelicalpha.com/resources/ibogaine-patent-tracker/ 2026-03-09T17:13:55+00:00 https://psychedelicalpha.com/resources/mdma-patent-tracker/ 2026-03-09T17:12:44+00:00 https://psychedelicalpha.com/resources/psilocybin-patent-filings-tracker/ 2026-03-09T17:12:24+00:00 https://psychedelicalpha.com/resources/5-meo-dmt-patent-tracker/ 2026-03-09T17:11:45+00:00 https://psychedelicalpha.com/resources/psychedelics-on-the-ballot-u-s-midterms-2022/ 2026-03-08T20:03:59+00:00 https://psychedelicalpha.com/terms-conditions/ 2026-01-24T08:43:35+00:00 https://psychedelicalpha.com/news/field-notes-6-dispatches-from-d-c-as-three-psychedelics-land-at-fda/ 2026-11-13T17:02:51+00:00 https://psychedelicalpha.com/news/field-notes-3-washingtons-busy-week-and-the-biggest-psychedelic-buyout-yet/ 2026-11-13T15:46:10+00:00 https://psychedelicalpha.com/news/field-notes-4-resilient-refiles-definiums-readout-hrsas-rfi-responses-and-jjs-neuroplastogen-bet/ 2026-11-13T15:45:53+00:00 https://psychedelicalpha.com/news/field-notes-5-psychedelics-week-in-washington-d-c/ 2026-11-13T15:45:43+00:00 https://psychedelicalpha.com/news/breaking-u-s-government-taps-mark-cubans-company-to-develop-ibogaine-for-ptsd-commits-to-fund-20m-real-world-evidence-network/ 2026-11-12T16:27:17+00:00 https://psychedelicalpha.com/news/220-patients-or-20000-clinics-split-on-psychedelics-first-year/ 2026-11-12T11:10:31+00:00 https://psychedelicalpha.com/news/news-feed/november-9-15-2026/ 2026-11-10T14:41:56+00:00 https://psychedelicalpha.com/news/breaking-compass-files-psilocybin-for-trd-new-drug-application-with-fda/ 2026-11-09T14:42:00+00:00 https://psychedelicalpha.com/news/news-feed/november-2-8-2026/ 2026-11-08T12:30:13+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-234-psychedelics-after-the-midterms-fda-answers-house-psychedelics-caucus-icer-to-review-compass-psilocybin-terran-v-compass-gets-trial-date/ 2026-11-06T15:07:27+00:00 https://psychedelicalpha.com/news/breaking-fda-rejects-lykos-therapeutics-mdma-assisted-therapy-for-ptsd/ 2026-11-05T15:16:39+00:00 https://psychedelicalpha.com/news/fda-approves-nrxs-preservative-free-generic-ketamine-but-its-bid-to-ban-rivals-products-remains-pending/ 2026-11-03T20:22:29+00:00 https://psychedelicalpha.com/news/compass-says-nda-will-be-filed-within-two-weeks-declines-to-comment-on-usona/ 2026-11-03T17:21:32+00:00 https://psychedelicalpha.com/news/usona-files-psilocybin-for-depression-nda-as-race-with-compass-tightens/ 2026-11-03T14:14:59+00:00 https://psychedelicalpha.com/news/the-state-of-the-psychedelic-industry-open-questions-video/ 2026-11-03T13:58:13+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q1-2026/ 2026-11-03T13:58:03+00:00 https://psychedelicalpha.com/news/a-dispatch-from-apas-annual-meeting-psychedelics-return-at-an-awkward-moment-for-american-psychiatry/ 2026-11-03T13:57:48+00:00 https://psychedelicalpha.com/news/breaking-definium-lands-positive-phase-3-lsd-candidate-shows-strong-antidepressant-effect/ 2026-11-03T13:57:26+00:00 https://psychedelicalpha.com/news/a-sea-change-with-caveats-a-closer-look-at-definiums-phase-3-lsd-for-mdd-readout/ 2026-11-03T13:57:11+00:00 https://psychedelicalpha.com/news/backed-by-11m-nida-grant-harvard-moves-forward-on-ibogaine-for-opioid-use-disorder-research/ 2026-11-03T13:56:53+00:00 https://psychedelicalpha.com/news/fda-issues-final-psychedelics-guidance-schedules-september-hearing-on-the-future-of-psychedelic-therapies/ 2026-11-03T13:51:03+00:00 https://psychedelicalpha.com/news/credentials-clinics-and-costs-stakeholders-respond-to-hrsas-psychedelic-therapy-rfi/ 2026-11-03T13:47:47+00:00 https://psychedelicalpha.com/news/a-closer-look-at-definiums-phase-3-lsd-for-gad-readout/ 2026-11-03T13:46:25+00:00 https://psychedelicalpha.com/news/davis-farchione-and-colleagues-present-fdas-psychedelic-drug-framework-in-nejm/ 2026-11-03T13:45:36+00:00 https://psychedelicalpha.com/news/definium-notches-second-positive-phase-3-in-generalised-anxiety-disorder/ 2026-11-03T13:45:13+00:00 https://psychedelicalpha.com/news/move-fast-with-precision-notes-from-arpa-hs-ibogaine-workshop/ 2026-11-03T13:44:26+00:00 https://psychedelicalpha.com/news/quarterly-psychedelics-briefing-q3-2026/ 2026-11-03T13:41:46+00:00 https://psychedelicalpha.com/news/mostly-supportive-somewhat-divided-stakeholders-respond-to-fdas-psychedelics-docket/ 2026-11-03T13:40:58+00:00 https://psychedelicalpha.com/news/pharma-moves-in-investors-developers-and-lillys-carole-ho-at-the-psychedelic-healthcare-forum/ 2026-11-03T13:40:32+00:00 https://psychedelicalpha.com/news/podcast-usona-files-psilocybin-application-we-review-610-comments-submitted-to-fda-and-fda-approves-nrxs-generic-ketamine/ 2026-11-02T15:04:38+00:00 https://psychedelicalpha.com/news/news-feed/october-26-november-1-2026/ 2026-11-01T13:10:24+00:00 https://psychedelicalpha.com/news/news-feed/october-19-25-2026/ 2026-10-28T12:57:45+00:00 https://psychedelicalpha.com/news/before-the-approvals-arrive-norway-germany-switzerland-the-uk-and-estonia-at-taip-conference-2026/ 2026-10-23T08:56:14+00:00 https://psychedelicalpha.com/news/ten-va-sites-rems-and-ibogaines-uphill-battle-feds-weigh-in-on-psychedelic-access/ 2026-10-22T14:16:32+00:00 https://psychedelicalpha.com/news/poacher-turned-gamekeeper-hhs-matt-zorn-on-ibogaine-right-to-try-and-the-psychedelics-executive-order/ 2026-10-21T13:40:02+00:00 https://psychedelicalpha.com/news/podcast-early-healthcare-forum-takeaways-fdas-ibogaine-blueprint-and-compass-talks-pricing/ 2026-10-20T11:40:55+00:00 https://psychedelicalpha.com/news/news-feed/october-12-18-2026/ 2026-10-18T12:46:15+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-7-preparedness-systems/ 2026-10-14T16:50:11+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-6-preparedness-people/ 2026-10-13T17:32:44+00:00 https://psychedelicalpha.com/news/news-feed/october-5-11-2026/ 2026-10-11T09:36:13+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-233-fda-floats-ibogaine-trial-design-compass-talks-pricing-potential-lsd-psilocybin-brand-names/ 2026-10-08T13:04:13+00:00 https://psychedelicalpha.com/news/oregon-backtracks-on-fee-hike-california-funds-psychedelic-research-dea-moves-to-schedule-5-tryptamines/ 2026-10-05T12:17:52+00:00 https://psychedelicalpha.com/news/news-feed/september-28-october-4-2026/ 2026-10-04T13:33:37+00:00 https://psychedelicalpha.com/news/approval-to-access-a-crude-schematic/ 2026-09-28T16:59:23+00:00 https://psychedelicalpha.com/news/news-feed/september-21-27-2026/ 2026-09-27T14:20:56+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-232-q226-psychedelic-lobbying-update-dea-again-moves-to-schedule-5-tryptamines-oregon-backpedals-psilocybin-fee-hike/ 2026-09-27T14:12:53+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-231-compass-shares-52-week-follow-up-training-grant-recipients-xylo-enters-the-clinic-rfk-jr-hosts-hubbard/ 2026-09-24T13:56:27+00:00 https://psychedelicalpha.com/news/introducing-the-psychedelic-news-feed-podcast/ 2026-09-21T13:44:21+00:00 https://psychedelicalpha.com/news/podcast-psychedelics-in-d-c-fdas-framework-and-new-zealands-mdma-prescribers/ 2026-09-21T13:42:13+00:00 https://psychedelicalpha.com/news/news-feed/september-14-20-2026/ 2026-09-20T12:16:56+00:00 https://psychedelicalpha.com/news/no-questions-asked-fdas-psychedelics-public-hearing/ 2026-09-15T13:54:17+00:00 https://psychedelicalpha.com/news/scoop-johnson-johnson-to-lead-delix-therapeutics-85m-series-c/ 2026-09-13T15:17:53+00:00 https://psychedelicalpha.com/news/news-feed/september-7-13-2026/ 2026-09-13T00:11:17+00:00 https://psychedelicalpha.com/news/news-feed/august-31-september-6-2026/ 2026-09-08T15:08:14+00:00 https://psychedelicalpha.com/news/two-new-zealand-psychiatrists-approved-to-prescribe-mdma-for-ptsd/ 2026-09-08T07:33:29+00:00 https://psychedelicalpha.com/news/p%ce%b1-library-psychedelic-rems/ 2026-09-04T14:23:45+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-230-pharma-ramps-up-ad-spend-on-psychedelic-keywords-arpa-hs-ibogaine-funding-psychedelics-in-medicaid/ 2026-09-01T14:08:20+00:00 https://psychedelicalpha.com/news/news-feed/august-24-30-2026/ 2026-08-30T12:28:42+00:00 https://psychedelicalpha.com/news/field-notes-1-psychiatrists-regulators-ibogaine-and-the-race-for-psilocybin-approval/ 2026-08-25T15:06:31+00:00 https://psychedelicalpha.com/news/field-notes-2-dispatches-from-london-and-the-netherlands/ 2026-08-25T15:04:12+00:00 https://psychedelicalpha.com/news/news-feed/august-17-23-2026/ 2026-08-22T19:57:06+00:00 https://psychedelicalpha.com/news/paving-the-way-husseini-manji-on-spravatos-lessons-for-psychedelic-drug-development/ 2026-08-18T17:24:05+00:00 https://psychedelicalpha.com/news/the-psychedelic-drug-development-pipeline-bullseye-chart-year-end-2023/ 2026-08-17T22:35:53+00:00 https://psychedelicalpha.com/news/q325-psychedelic-drug-development-pipeline-bullseye-charts/ 2026-08-17T22:29:13+00:00 https://psychedelicalpha.com/news/q326-psychedelic-drug-development-pipeline-bullseye-charts/ 2026-08-17T22:25:31+00:00 https://psychedelicalpha.com/news/bullseye-chart-the-psychedelic-drug-development-pipeline/ 2026-08-17T22:23:24+00:00 https://psychedelicalpha.com/news/q125-psychedelic-drug-development-pipeline-bullseye-chart/ 2026-08-17T22:22:50+00:00 https://psychedelicalpha.com/news/q1-2026-psychedelic-drug-development-pipeline-bullseye-charts/ 2026-08-17T22:19:39+00:00 https://psychedelicalpha.com/news/news-feed/august-10-16-2026/ 2026-08-15T15:16:44+00:00 https://psychedelicalpha.com/news/smooth-sailing-definiums-lsd-voyage-hits-primary-and-key-secondary-endpoints-in-gad/ 2026-08-14T15:50:07+00:00 https://psychedelicalpha.com/news/two-years-after-rejection-resilient-quietly-refiles-mdma-for-ptsd-application/ 2026-08-12T22:57:58+00:00 https://psychedelicalpha.com/news/news-feed/august-3-9-2026/ 2026-08-09T14:38:32+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-229-samhsa-convenes-experts-ataibeckleys-road-to-lilly-turnbull-doubles-down-on-bol-148-compass-talks-indication-expansion-could-va-help/ 2026-08-09T14:19:46+00:00 https://psychedelicalpha.com/news/from-sonora-to-big-pharma-kimon-de-greef-traces-the-strange-rise-of-5-meo-dmt/ 2026-08-04T15:23:20+00:00 https://psychedelicalpha.com/news/news-feed/july-27-august-2-2026/ 2026-08-01T17:37:44+00:00 https://psychedelicalpha.com/news/psychedelic-alpha-crossword-summer-2026/ 2026-07-31T15:34:44+00:00 https://psychedelicalpha.com/news/beyond-the-biological-baseline-dr-grace-blest-hopley-on-developing-female-inclusive-psychedelic-frameworks/ 2026-07-30T16:30:27+00:00 https://psychedelicalpha.com/news/q1-2026-oregon-psilocybin-services-update/ 2026-07-27T15:00:30+00:00 https://psychedelicalpha.com/news/news-feed/july-20-26-2026/ 2026-07-26T14:59:06+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q2-2026/ 2026-07-24T14:41:06+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-228-inside-the-lilly-atai-deal-an-update-on-the-gh-ataibeckley-patent-standoff-field-reacts-to-fdas-guidance-resilient-readies-resubmission/ 2026-07-22T22:07:55+00:00 https://psychedelicalpha.com/news/news-feed/july-13-19-2026/ 2026-07-19T14:01:19+00:00 https://psychedelicalpha.com/news/episode/field-notes-3_-washingtons-busy-week-and-the-biggest-psychedelic-buyout-yet/ 2026-07-17T16:12:39+00:00 https://psychedelicalpha.com/news/breaking-worlds-largest-pharmaceutical-company-eli-lilly-acquires-5-meo-dmt-developer-ataibeckley-for-up-to-3-8-billion/ 2026-07-16T12:48:20+00:00 https://psychedelicalpha.com/news/keeping-up-with-the-feds-from-fda-to-hrsa-washington-backs-psychedelics/ 2026-07-13T21:03:13+00:00 https://psychedelicalpha.com/news/news-feed/july-6-12-2026/ 2026-07-12T10:59:11+00:00 https://psychedelicalpha.com/news/breaking-fda-awards-priority-review-vouchers-to-otsuka-compass-and-usona/ 2026-07-08T11:29:22+00:00 https://psychedelicalpha.com/news/compass-closes-out-phase-3-with-6-month-comp006-data-eyes-h127-launch/ 2026-07-08T11:20:44+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-227-a-closer-look-at-compass-6-month-data-ataibeckley-deal-update-rysanso-brand-mdma/ 2026-07-08T10:53:16+00:00 https://psychedelicalpha.com/news/quarterly-briefing-q2-2026/ 2026-07-05T08:55:52+00:00 https://psychedelicalpha.com/news/news-feed/june-29-july-5-2026/ 2026-07-04T09:23:33+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-226-the-ethics-of-psilocybin-for-advanced-alzheimers-veterans-views-on-psychedelics/ 2026-06-29T10:55:50+00:00 https://psychedelicalpha.com/news/news-feed/june-22-28-2026/ 2026-06-27T20:18:01+00:00 https://psychedelicalpha.com/news/a-research-hypothesis-not-a-treatment-recommendation-marcos-lago-on-the-viral-psilocybin-for-alzheimers-case-report/ 2026-06-26T11:45:14+00:00 https://psychedelicalpha.com/news/2023-annotated-interdisciplinary-psychedelics-bibliography/ 2026-06-24T15:19:04+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-1/ 2026-06-24T13:17:40+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-2-preparation/ 2026-06-24T12:57:55+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-3-dosing/ 2026-06-24T12:57:26+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-4-integration/ 2026-06-24T12:56:36+00:00 https://psychedelicalpha.com/news/episode/field-notes-2-dispatches-from-london-and-the-netherlands/ 2026-06-22T09:42:57+00:00 https://psychedelicalpha.com/news/news-feed/june-15-21-2026/ 2026-06-20T16:22:13+00:00 https://psychedelicalpha.com/news/the-psychedelic-practitioner-issue-5-groups-in-practice/ 2026-06-19T14:37:55+00:00 https://psychedelicalpha.com/news/psilocybin-compassionate-use-in-germany-lea-mertens-and-andrea-jungaberle-on-the-first-patients-payers-and-practicalities/ 2026-06-17T14:37:18+00:00 https://psychedelicalpha.com/news/momentum-amidst-tumult-the-fda-reshuffle-approval-timelines-and-the-compass-usona-race/ 2026-06-17T13:57:20+00:00 https://psychedelicalpha.com/news/news-feed/may-11-may-17-2026/ 2026-06-15T09:13:53+00:00 https://psychedelicalpha.com/news/news-feed/june-8-14-2026/ 2026-06-13T09:09:15+00:00 https://psychedelicalpha.com/news/may-2026-psychedelic-bill-roundup/ 2026-06-10T11:45:54+00:00 https://psychedelicalpha.com/news/news-feed/june-1-june-7-2026/ 2026-06-09T11:08:45+00:00 https://psychedelicalpha.com/news/news-feed/may-25-may-31-2026/ 2026-06-09T11:08:38+00:00 https://psychedelicalpha.com/news/news-feed/may-18-may-24-2026/ 2026-06-09T11:08:31+00:00 https://psychedelicalpha.com/news/news-feed/may-4-may-10-2026/ 2026-06-09T11:08:19+00:00 https://psychedelicalpha.com/news/news-feed/april-20-april-26-2026/ 2026-06-09T11:08:03+00:00 https://psychedelicalpha.com/news/news-feed/april-13-april-19-2026/ 2026-06-09T11:07:55+00:00 https://psychedelicalpha.com/news/news-feed/april-6-april-12-2026/ 2026-06-09T11:07:35+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-225-q1-lobbying-update-individual-vs-group-mdma-therapy-study-launches-australia-loosens-psychedelics-access-regulations-va-launches-new-mdma-tria/ 2026-06-05T10:13:40+00:00 https://psychedelicalpha.com/news/episode/10091/ 2026-05-26T19:46:17+00:00 https://psychedelicalpha.com/news/news-feed/october-6-12-2025/ 2026-05-25T14:14:31+00:00 https://psychedelicalpha.com/news/news-feed/october-20-26-2025/ 2026-05-25T14:09:30+00:00 https://psychedelicalpha.com/news/news-feed/october-27-november-02-2025/ 2026-05-25T14:06:46+00:00 https://psychedelicalpha.com/news/news-feed/january-19-25-2026/ 2026-05-25T14:04:40+00:00 https://psychedelicalpha.com/news/news-feed/febraury-09-15-2026/ 2026-05-25T14:02:21+00:00 https://psychedelicalpha.com/news/news-feed/february-16-22-2026/ 2026-05-25T14:00:48+00:00 https://psychedelicalpha.com/news/bit-yaden-on-preparing-the-next-generation-of-psychiatrists-for-a-psychedelic-future/ 2026-05-22T15:36:21+00:00 https://psychedelicalpha.com/news/if-i-cant-change-my-views-based-on-evidence-then-why-do-science-at-all-nora-volkow-on-psychedelics/ 2026-05-19T16:03:32+00:00 https://psychedelicalpha.com/news/q4-2025-oregon-psilocybin-services-update/ 2026-05-15T14:41:53+00:00 https://psychedelicalpha.com/news/q3-2025-oregon-psilocybin-services-update/ 2026-05-14T15:01:31+00:00 https://psychedelicalpha.com/news/psilocybin-for-chronic-suicidal-ideation-scott-t-aaronson-on-safety-an-efficacy-signal-and-the-role-of-expectations/ 2026-05-13T17:47:01+00:00 https://psychedelicalpha.com/news/april-2026-psychedelic-bill-round-up/ 2026-05-12T13:19:39+00:00 https://psychedelicalpha.com/news/god-gabon-and-government-w-bryan-hubbard-on-ibogaine-the-executive-order-and-what-comes-next/ 2026-05-11T11:13:59+00:00 https://psychedelicalpha.com/news/psilocybin-for-cocaine-use-disorder-peter-hendricks-on-a-trial-ten-years-in-the-making/ 2026-05-07T16:57:58+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-224-reactions-to-trumps-psychedelics-executive-order-and-what-comes-next-pre-eo-dea-poured-cold-water-on-right-to-try/ 2026-05-06T13:45:54+00:00 https://psychedelicalpha.com/news/first-non-palliative-canadian-granted-access-to-psilocybin-therapy/ 2026-05-05T11:55:28+00:00 https://psychedelicalpha.com/news/psychedelic-bulletin-atai-scoops-157m-efficacy-of-microdosing-under-scrutiny-bright-minds-reduces-bing-eating-in-rats/ 2026-05-05T11:53:28+00:00 https://psychedelicalpha.com/news/psychedelic-bulletin-mindmed-co-founder-resigns-from-board-global-coalition-to-reschedule-psilocybin-emerges-we-review-psychedelic-research-and-trials-from-2021/ 2026-05-05T11:50:19+00:00 https://psychedelicalpha.com/news/psychedelic-bulletin-mdma-ptsd-cost-effective/ 2026-05-05T11:49:40+00:00 https://psychedelicalpha.com/news/australia-recognises-mdma-and-psilocybin-as-medicines/ 2026-05-05T11:43:29+00:00 https://psychedelicalpha.com/news/psychedelic-bulletin-140-regulators-weigh-in-on-psychedelics-psychedelic-biotech-strikes-big-pharma-agreement-gh-publishes-5-meo-dmt-trial/ 2026-05-05T11:41:41+00:00 https://psychedelicalpha.com/news/p%ce%b1-library-bifurcated-scheduling/ 2026-05-05T11:37:15+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-november-2023/ 2026-05-05T11:36:10+00:00 https://psychedelicalpha.com/news/psychedelic-funding-public-markets-in-2023/ 2026-05-05T11:35:17+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-bulletin-154-public-tara-mind-scores-8m-seed-updates-on-state-psychedelics-programs/ 2026-05-05T11:34:46+00:00 https://psychedelicalpha.com/news/psychedelic-policy-reform-legal-markets-in-2023/ 2026-05-05T11:34:08+00:00 https://psychedelicalpha.com/news/p%ce%b1-dispatch-from-advancing-psychedelic-clinical-study-design-hosted-by-the-reagan-udall-foundation-for-the-fda-part-1/ 2026-05-05T11:31:21+00:00 https://psychedelicalpha.com/news/p%ce%b1-day-2-dispatch-from-advancing-psychedelic-clinical-study-design-hosted-by-the-reagan-udall-foundation-for-the-fda/ 2026-05-05T11:30:58+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-a-mebufotenin-melee-dec-23-jan-24/ 2026-05-05T11:30:35+00:00 https://psychedelicalpha.com/news/ibogaine-advocates-seek-ohio-opioid-settlement-funds-following-failure-in-kentucky/ 2026-05-05T11:29:57+00:00 https://psychedelicalpha.com/news/prominent-at-home-ketamine-co-founder-juan-pablo-cappello-sounds-alarm-withdraws-support-for-the-practice/ 2026-05-05T11:29:15+00:00 https://psychedelicalpha.com/news/fda-hands-mindmeds-lsd-candidate-breakthrough-therapy-designation-in-generalised-anxiety-disorder-company-provides-12-week-data-and-fleshes-out-phase-3-program-plans/ 2026-05-05T11:29:01+00:00 https://psychedelicalpha.com/news/cybin-scores-breakthrough-therapy-designation-for-deuterated-psilocybin-analog-in-mdd-shares-4-month-data/ 2026-05-05T11:28:43+00:00 https://psychedelicalpha.com/news/gilgamesh-scoops-14m-from-nida-to-develop-safer-ibogaine-analog-for-opioid-use-disorder/ 2026-05-05T11:28:26+00:00 https://psychedelicalpha.com/news/icer-draft-evidence-report-on-lykos-mdma-assisted-psychotherapy-deems-clinical-evidence-insufficient/ 2026-05-05T11:28:01+00:00 https://psychedelicalpha.com/news/p%ce%b1-psychedelic-patent-analysis-february-2024/ 2026-05-05T11:27:43+00:00 https://psychedelicalpha.com/news/mindmeds-total-elimination-of-psychotherapy-in-lsd-study-stokes-debate-around-its-role-in-psychedelic-therapies/ 2026-05-05T11:27:17+00:00 https://psychedelicalpha.com/news/insights-from-the-european-medicines-agencys-psychedelics-workshop-a-p%ce%b1-dispatch/ 2026-05-05T11:26:40+00:00 https://psychedelicalpha.com/news/reunion-neuroscience-gets-a-new-lease-of-life-with-103m-series-a-to-fund-phase-2-studies-of-4-ho-dipt-prodrug/ 2026-05-05T11:26:06+00:00 https://psychedelicalpha.com/news/fda-advisory-committee-to-review-lykos-therapeutics-mdma-assisted-therapy-in-early-june/ 2026-05-05T11:25:50+00:00 https://psychedelicalpha.com/news/the-church-of-the-eagle-and-the-condor-settles-with-federal-agencies-can-continue-importing-and-using-ayahuasca/ 2026-05-05T11:25:35+00:00 https://psychedelicalpha.com/news/european-medicines-agency-cmo-talks-psychedelics-and-their-therapeutic-use-in-live-qa/ 2026-05-05T11:25:20+00:00 https://psychedelicalpha.com/news/breaking-abbvie-inks-deal-with-gilgamesh-pharmaceuticals/ 2026-05-05T11:24:52+00:00 https://psychedelicalpha.com/news/industry-and-researchers-respond-to-icer-report-on-mdma-assisted-therapy-which-maintains-lykos-clinical-evidence-is-insufficient/ 2026-05-05T11:24:41+00:00 https://psychedelicalpha.com/news/were-going-to-see-demand-for-this-go-through-the-roof-va-under-secretary-for-health-shares-how-the-agency-is-preparing-for-mdma-psilocybin-therapies/ 2026-05-05T11:24:28+00:00 https://psychedelicalpha.com/news/what-to-expect-fda-advisory-committee-set-to-review-mdma-assisted-therapy-for-ptsd/ 2026-05-05T11:24:03+00:00 https://psychedelicalpha.com/news/patients-practitioners-researchers-and-public-submit-comments-ahead-of-fda-advisory-committee-on-mdma/ 2026-05-05T11:23:50+00:00 https://psychedelicalpha.com/news/icer-panel-rejects-mdma-assisted-therapy-highlights-evidence-gaps-and-study-flaws-in-14-1-vote/ 2026-05-05T11:23:37+00:00 https://psychedelicalpha.com/news/live-coverage-fda-advisory-committee-reviews-mdma-assisted-therapy-for-ptsd/ 2026-05-05T11:23:21+00:00 https://psychedelicalpha.com/news/analysis-fda-advisory-committee-snubs-mdma-assisted-therapy-for-ptsd-in-overwhelming-no-vote/ 2026-05-05T11:23:08+00:00 https://psychedelicalpha.com/news/breaking-lykos-therapeutics-moved-to-patent-mdma-in-late-2022-filing-reveals/ 2026-05-05T11:22:45+00:00 https://psychedelicalpha.com/news/no-nhs-coverage-for-janssens-spravato-nice-denies-re-appraisal-of-esketamine-for-trd/ 2026-05-05T11:22:21+00:00 https://psychedelicalpha.com/news/in-brief-icer-issues-final-evidence-report-and-recommendations-re-mdma-assisted-therapy-lykos-responds/ 2026-05-05T11:20:55+00:00 https://psychedelicalpha.com/news/dutch-committee-seeks-to-expedite-mdma-assisted-therapy-for-ptsd/ 2026-05-05T11:20:30+00:00 https://psychedelicalpha.com/news/regulation-beyond-prohibition-rand-corporation-delivers-report-on-us-psychedelic-policymaking/ 2026-05-05T11:19:49+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q2-2024/ 2026-05-05T11:19:24+00:00 https://psychedelicalpha.com/news/vibe-check-fda-set-to-decide-future-of-mdma-assisted-therapy-this-week/ 2026-05-05T11:19:08+00:00 https://psychedelicalpha.com/news/breaking-lykos-lays-off-75-of-staff-ropes-in-pharma-veteran-doblin-resigns-board/ 2026-05-05T11:18:18+00:00 https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-1/ 2026-05-05T11:17:54+00:00 https://psychedelicalpha.com/news/what-does-fda-expect-from-lykos-next-phase-3-mdma-study-part-2/ 2026-05-05T11:17:38+00:00 https://psychedelicalpha.com/news/real-world-data-reveals-variability-in-access-to-and-use-of-spravato/ 2026-05-05T11:17:05+00:00 https://psychedelicalpha.com/news/the-psychedelics-lobby-tracking-federal-lobbying-by-psychedelics-companies-and-nonprofits/ 2026-05-05T11:16:38+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q3-2024/ 2026-05-05T11:16:26+00:00 https://psychedelicalpha.com/news/massachusetts-psychiatrists-push-back-on-psychedelic-reform-as-ballot-vote-looms-an-interview-with-nassir-ghaemi/ 2026-05-05T11:16:10+00:00 https://psychedelicalpha.com/news/psychedelics-take-centre-stage-in-massachusetts-local-media/ 2026-05-05T11:15:34+00:00 https://psychedelicalpha.com/news/final-stretch-for-question-4-controversy-advocacy-and-celebrity-voices-shape-psychedelic-vote/ 2026-05-05T11:15:11+00:00 https://psychedelicalpha.com/news/compass-pathways-pushes-back-phase-3-readouts-lays-off-30-of-staff/ 2026-05-05T11:14:50+00:00 https://psychedelicalpha.com/news/backed-by-15m-in-nida-funding-nyu-and-b-more-team-up-to-trial-psilocybin-for-opioid-use-disorder/ 2026-05-05T11:14:35+00:00 https://psychedelicalpha.com/news/bipartisan-momentum-or-radical-reform-insiders-weigh-in-on-the-future-of-psychedelic-research-and-regulation-under-trump-or-harris/ 2026-05-05T11:14:15+00:00 https://psychedelicalpha.com/news/psychedelics-advocates-urge-yes-on-question-4-amid-last-minute-debates/ 2026-05-05T11:14:01+00:00 https://psychedelicalpha.com/news/psychedelics-on-the-ballot-2024/ 2026-05-05T11:13:42+00:00 https://psychedelicalpha.com/news/question-4-fails-massachusetts-says-no-to-state-regulated-psychedelics-access-and-decriminalisation/ 2026-05-05T11:13:27+00:00 https://psychedelicalpha.com/news/tripping-over-trump-will-the-new-administration-embrace-psychedelic-exceptionalism-or-just-say-no/ 2026-05-05T11:12:58+00:00 https://psychedelicalpha.com/news/dispatch-from-the-dea-doi-and-doc-on-trial-as-scientists-challenge-psychedelic-scheduling-bid/ 2026-05-05T11:12:37+00:00 https://psychedelicalpha.com/news/psychedelic-investor-survey-q3-2024/ 2026-05-05T11:12:22+00:00 https://psychedelicalpha.com/news/interviews-meet-the-team-who-challenged-the-dea-on-doi-and-doc/ 2026-05-05T11:11:50+00:00 https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-excited-about/ 2026-05-05T11:11:48+00:00 https://psychedelicalpha.com/news/q324-survey-what-are-psychedelics-investors-concerned-about/ 2026-05-05T11:10:43+00:00 https://psychedelicalpha.com/news/psychedelic-drug-development-under-trump-2-0-health-nominees-signal-uncertain-future/ 2026-05-05T11:09:47+00:00 https://psychedelicalpha.com/news/scoop-psfcs-130m-roadmap-to-shape-the-future-of-psychedelic-philanthropy/ 2026-05-05T11:09:12+00:00 https://psychedelicalpha.com/news/psychedelic-alphas-top-11-stories-from-2024/ 2026-05-05T11:08:58+00:00 https://psychedelicalpha.com/news/from-fringe-to-focus-apas-american-journal-of-psychiatry-publishes-special-issue-on-psychedelics/ 2026-05-05T11:06:54+00:00 https://psychedelicalpha.com/news/billionaire-investor-antonio-gracias-plots-100m-lykos-takeover-with-doblins-backing/ 2026-05-05T11:06:33+00:00 https://psychedelicalpha.com/news/psychedelicare-launches-first-european-citizens-initiative-demanding-political-action-on-psychedelic-assisted-therapies/ 2026-05-05T11:06:14+00:00 https://psychedelicalpha.com/news/patent-analysis-lykos-suffers-blow-from-uspto-as-all-patent-claims-stand-finally-rejected/ 2026-05-05T11:05:59+00:00 https://psychedelicalpha.com/news/psychedelics-in-2024-from-hype-to-hard-realities/ 2026-05-05T11:05:10+00:00 https://psychedelicalpha.com/news/bifurcation-squared-compass-lobbies-for-narrow-rescheduling-in-colorado-virginia-pushes-back-on-state-policy-reforms/ 2026-05-05T11:04:58+00:00 https://psychedelicalpha.com/news/psychedelic-drug-development-pipeline-updates-q125/ 2026-05-05T11:04:20+00:00 https://psychedelicalpha.com/news/2025s-psychedelic-policy-surge-a-state-by-state-bill-by-bill-analysis/ 2026-05-05T11:03:40+00:00 https://psychedelicalpha.com/news/gh-research-reports-strong-phase-2b-results-for-5-meo-dmt-in-treatment-resistant-depression/ 2026-05-05T11:03:20+00:00 https://psychedelicalpha.com/news/ketamine-on-the-edge-mindblooms-at-home-injections-spark-debate-uk-eyes-tougher-laws-dea-to-regulate-telehealth-prescribing-spravato-sales-top-1bn/ 2026-05-05T11:02:37+00:00 https://psychedelicalpha.com/news/psychedelic-funding-public-markets-and-ma-in-2024/ 2026-05-05T11:02:16+00:00 https://psychedelicalpha.com/news/uk-psychedelic-research-hindered-by-red-tape-experts-tell-lawmakers-in-parliamentary-report/ 2026-05-05T11:01:32+00:00 https://psychedelicalpha.com/news/january-2025-psychedelic-patent-update-lykos-new-continuation-applications-ambio-files-on-ibogaine-magnesium/ 2026-05-05T11:00:58+00:00 https://psychedelicalpha.com/news/psychedelic-policy-push-continues-over-60-bills-introduced-across-22-states/ 2026-05-05T11:00:29+00:00 https://psychedelicalpha.com/news/a-rundown-of-colorados-natural-medicine-program/ 2026-05-05T10:59:37+00:00 https://psychedelicalpha.com/news/behind-the-scenes-of-the-psychedelic-renaissance-at-sxsw-2025/ 2026-05-05T10:54:51+00:00 https://psychedelicalpha.com/news/beyond-guinea-pigs-ensuring-access-to-psychedelic-therapies-for-europeans/ 2026-05-05T10:54:13+00:00 https://psychedelicalpha.com/news/february-2025-psychedelic-patent-update-terran-secures-new-overlapping-ip-porta-sophia-becomes-uspto-information-source/ 2026-05-05T10:53:55+00:00 https://psychedelicalpha.com/news/transcend-posts-positive-phase-2-data-from-methylone-for-ptsd-program/ 2026-05-05T10:53:33+00:00 https://psychedelicalpha.com/news/march-2025s-psychedelic-policy-momentum-new-bills-filed-across-the-u-s-as-nearly-30-states-deliberate-reforms/ 2026-05-05T10:52:03+00:00 https://psychedelicalpha.com/news/psychedelic-policy-update-medical-access-industry-influence-and-voter-suppression-shape-2025-landscape/ 2026-05-04T14:00:10+00:00 https://psychedelicalpha.com/news/high-hopes-in-the-mile-high-city-inside-colorados-first-licensed-psilocybin-center/ 2026-05-04T13:59:41+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q1-2025/ 2026-05-04T13:59:21+00:00 https://psychedelicalpha.com/news/march-filings-provide-first-look-at-seaports-2-bromo-lsd-program-delixs-ergoline-analogues-caamtechs-spinout/ 2026-05-04T13:58:40+00:00 https://psychedelicalpha.com/news/dispatch-from-breaking-convention-2025-insights-from-europes-largest-psychedelic-research-conference-part-1/ 2026-05-04T13:58:23+00:00 https://psychedelicalpha.com/news/exclusive-heroic-hearts-and-healing-breakthrough-merge-to-expand-stateside-psychedelic-access-for-veterans/ 2026-05-04T13:56:49+00:00 https://psychedelicalpha.com/news/colorados-psilocybin-supply-chain-complete-first-testing-lab-licensed-sessions-could-begin-this-month/ 2026-05-04T13:56:35+00:00 https://psychedelicalpha.com/news/dispatch-from-breaking-convention-2025-key-takeaways-from-europes-largest-psychedelic-summit-part-2/ 2026-05-04T13:56:24+00:00 https://psychedelicalpha.com/news/spring-2025-psychedelic-policy-update-bills-hang-in-the-balance-as-legislative-sessions-wind-down/ 2026-05-04T13:55:17+00:00 https://psychedelicalpha.com/news/fdas-makary-hints-at-faster-reviews-for-psychedelic-therapies/ 2026-05-04T13:54:58+00:00 https://psychedelicalpha.com/news/matt-zorn-the-governments-former-adversary-is-now-its-psychedelics-czar/ 2026-05-04T13:53:29+00:00 https://psychedelicalpha.com/news/breaking-atai-moves-to-acquire-beckley-if-phase-2b-5-meo-dmt-data-delivers/ 2026-05-04T13:52:50+00:00 https://psychedelicalpha.com/news/the-backyard-psychedelic-renaissance-how-bottom-up-change-is-delivering-psychedelic-access/ 2026-05-04T13:52:30+00:00 https://psychedelicalpha.com/news/may-2025-psychedelic-patent-update-gilgamesh-broadens-moat-around-lead-candidate-following-positive-phase-2a-readout-lykos-publishes-further-continuation-applications-reconnect-joins-crowded-5-meo/ 2026-05-04T13:50:00+00:00 https://psychedelicalpha.com/news/australias-largest-private-health-insurer-commits-10m-to-fund-mdma-therapy-for-ptsd-in-first-of-its-kind-program/ 2026-05-04T13:49:15+00:00 https://psychedelicalpha.com/news/compass-pathways-psilocybin-clears-first-phase-3-hurdle/ 2026-05-04T13:48:38+00:00 https://psychedelicalpha.com/news/cautious-optimism-lingering-questions-researchers-react-to-compass-phase-3-psilocybin-results/ 2026-05-04T13:48:22+00:00 https://psychedelicalpha.com/news/beyond-the-endpoint-industry-voices-reflect-on-compass-phase-3-readout/ 2026-05-04T13:48:04+00:00 https://psychedelicalpha.com/news/beckleys-5-meo-dmt-shows-rapid-durable-antidepressant-effects-in-phase-2b-study/ 2026-05-04T13:47:41+00:00 https://psychedelicalpha.com/news/beckley-and-atai-leadership-unpack-phase-2b-data-take-aim-at-ghs-dosing-model/ 2026-05-04T13:47:21+00:00 https://psychedelicalpha.com/news/oregon-psilocybin-services-tracker-q1-2025/ 2026-05-04T13:47:01+00:00 https://psychedelicalpha.com/news/psychedelic-funding-update-q2-2025/ 2026-05-04T13:46:41+00:00 https://psychedelicalpha.com/news/dispatch-the-neurobiology-of-psychedelics-gordon-research-conference-plasticity-psychotherapy-and-perception-part-1/ 2026-05-04T13:46:25+00:00 https://psychedelicalpha.com/news/june-2025-psychedelic-patent-update/ 2026-05-04T13:45:20+00:00 https://psychedelicalpha.com/news/dispatch-the-neurobiology-of-psychedelics-gordon-research-conference-circuitry-consciousness-and-clinical-horizons-part-2/ 2026-05-04T13:45:00+00:00 https://psychedelicalpha.com/news/germany-establishes-eus-first-psilocybin-compassionate-access-program/ 2026-05-04T13:44:38+00:00 https://psychedelicalpha.com/news/one-year-after-fdas-mdma-rejection-insiders-and-observers-reflect/ 2026-05-04T13:43:58+00:00 https://psychedelicalpha.com/news/reunion-neuroscience-posts-strong-phase-2-results-for-re104-in-postpartum-depression/ 2026-05-04T13:43:43+00:00 https://psychedelicalpha.com/news/abbvie-to-acquire-gilgameshs-bretisilocin-for-up-to-1-2b/ 2026-05-04T13:43:22+00:00 https://psychedelicalpha.com/news/psychedelic-researchers-respond-to-fdas-push-to-reduce-animal-testing/ 2026-05-04T13:42:57+00:00 https://psychedelicalpha.com/news/breaking-fda-publishes-lykos-therapeutics-mdma-complete-response-letter-crl/ 2026-05-04T13:42:06+00:00 https://psychedelicalpha.com/news/unpacking-fdas-mdma-rejection-letter-and-the-road-ahead-for-lykos/ 2026-05-04T13:41:50+00:00 https://psychedelicalpha.com/news/uk-royal-college-of-psychiatrists-weighs-in-promise-in-psychedelics-but-hype-mustnt-outpace-evidence/ 2026-05-04T13:41:21+00:00